Mark Ford is a counsel in the firm's Litigation/Controversy and Regulatory and Government Affairs Departments, and a member of the Business Trial Group and Antitrust and Competition Practice Group. Mr. Ford joined the firm in 2003.
Practice
Mr. Ford specializes in antitrust litigation and government investigations. He has represented companies, including a number of pharmaceutical and telecommunications companies, in a variety of antitrust matters as well as False Claims Act litigation. In particular, he has extensive experience litigating disputes at the intersection of antitrust and intellectual property including Hatch-Waxman Act cases and litigation involving telecommunications industry standards setting practices.
Recent Highlights
- Represented Cephalon, Inc. in a Federal Trade Commission investigation as well as in federal antitrust litigation pending in the Eastern District of Pennsylvania relating to drug patent settlement agreements.
- Represented Braintree Laboratories, Inc., a Massachusetts-based pharmaceutical company, in defense of federal antitrust claims arising from alleged sham litigation, prevailing at trial before the United States District Court for the District of Delaware, and successfully dismissing follow-on class action litigation involving indirect purchasers.
- Represented Research in Motion Ltd. in an antitrust claims against Motorola, Inc. arising from alleged refusal to offer fair and reasonable licensing terms for standards-essential patents, successfully defeating a motion to dismiss those claims before the United States District Court for the Northern District of Texas.
- Represented international pharmaceutical company in Department of Justice investigation involving federal False Claims Act allegations arising from drug marketing practices.
Professional Activities
Mr. Ford is a former co-chair of the Antitrust Committee of the Boston Bar Association.
